Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Sniderman

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
European Heart Journal|October 2, 2007
The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndromeAllan D Sniderman
Journal of Clinical Lipidology|June 24, 2019
Did the ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA cholesterol guidelines get apoB right?Allan D Sniderman
European Journal of Preventive Cardiology|November 19, 2022
Apolipoprotein B versus non-high-density lipoprotein cholesterol: contradictory results in the same journalAllan D Sniderman
The American Journal of Cardiology|November 7, 2002
How, when, and why to use apolipoprotein B in clinical practiceAllan D Sniderman
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 26, 2002
Lipoprotein(a) and atherogenesis: a puzzle inside a riddle within an enigmaAllan D Sniderman
Journal of Clinical Lipidology|February 5, 2011
Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practiceAllan D Sniderman
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to goAllan D Sniderman
Journal of Clinical Lipidology|July 26, 2011
Can conclusions that seem discordant be concordant after all?Allan D Sniderman
The American Journal of Cardiology|November 3, 2004
Is there value in liver function test and creatine phosphokinase monitoring with statin use?Allan D Sniderman
Current Opinion in Lipidology|July 10, 2004
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithmAllan D Sniderman
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
European Heart Journal|October 2, 2007
The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndromeAllan D Sniderman
Journal of Clinical Lipidology|June 24, 2019
Did the ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA cholesterol guidelines get apoB right?Allan D Sniderman
European Journal of Preventive Cardiology|November 19, 2022
Apolipoprotein B versus non-high-density lipoprotein cholesterol: contradictory results in the same journalAllan D Sniderman
The American Journal of Cardiology|November 7, 2002
How, when, and why to use apolipoprotein B in clinical practiceAllan D Sniderman
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 26, 2002
Lipoprotein(a) and atherogenesis: a puzzle inside a riddle within an enigmaAllan D Sniderman
Journal of Clinical Lipidology|February 5, 2011
Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practiceAllan D Sniderman
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to goAllan D Sniderman
Journal of Clinical Lipidology|July 26, 2011
Can conclusions that seem discordant be concordant after all?Allan D Sniderman
The American Journal of Cardiology|November 3, 2004
Is there value in liver function test and creatine phosphokinase monitoring with statin use?Allan D Sniderman
Current Opinion in Lipidology|July 10, 2004
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithmAllan D Sniderman
Pageof 17